America has struggled to meet the potential it requires for coronavirus research, a top public health officially confirmed Thursday.
“The program isn’t really tailored to what we need right now,” said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, in a House hearing about U.S. coronavirus test kits that were initially plagued by technological glitches. “That’s a disappointment. Let’s face it.”
Fauci answered a question from Rep. Debbie Wasserman Schultz, D-Florida, who asked about a report from the National Nurses United trade association claiming that a study was rejected for it by “countless” health care employees exposed to coronavirus.
The Centers for Disease Control and Prevention had specific guidelines on who should be screened for it when the virus first began to emerge in America, further restricting the number of studies done on top of the technological issues. The guidelines have been extended ever since. CDC chief Dr. Robert Redfield, who also appeared at the trial, answered Fauci’s request to Wasserman Schultz.